Advances of the mechanism study on berberine in the control of blood glucose and lipid as well as metabolism disorders

Yaoxue Xuebao

Volumn 45, Issue 6, 2010, Pages 699-704

  Shen, Ning ^a   Li, Cai Na ^a   Huan, Yi ^a   Shen, Zhu Fang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Berberine; Diabetes; Pancreatic cell

Indexed keywords

BERBERINE;

BLOOD GLUCOSE MONITORING; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; METABOLIC DISORDER; PANCREAS ISLET BETA CELL; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BERBERINE; BLOOD GLUCOSE; COPTIS; DIABETES MELLITUS; DRUGS, CHINESE HERBAL; HUMANS; INSULIN; INSULIN-SECRETING CELLS; METABOLIC DISEASES; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLANTS, MEDICINAL; PROTEIN KINASES; RECEPTORS, LDL; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 77956799286     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins [J]. Nat Med, 2004, 10: 1344-1352.
2. Abidi P, Zhou Y, Jiang JD, et al. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine [J]. Arterioscler Thromb Vasc Biol, 2005, 25: 2170-2176.
3. Li H, Chen W, Zhou Y, et al. Identification of mRNA-binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements [J]. J Lipid Res, 2009, 50: 820-831.
4. Lee S, Lim HJ, Park JH, et al. Berberine-induced LDLR up-regulation involves JNK pathway [J]. Biochem Biophys Res Commun, 2007, 362: 853-857.
5. Cameron J, Ranheim T, Kulseth MA, et al. Berberine decreases PCSK9 expression in HepG2 cells [J]. Atherosclerosis, 2008, 201: 266-273.
6. Li H, Dong B, Park SW, et al. HNF1α plays a critical role in PCSK9 gene transcription and regulation by a natural hypocholesterolemic compound berberine [J]. J Biol Chem, 2009, 284: 28885-28895.
7. Huang C, Zhang Y, Gong Z, et al. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway [J]. Biochem Biophys Res Commun, 2006, 348: 571-578.
8. Liu Y, Wang WJ, Li YS, et al. Effect of berberine on visfatin expression in 3T3-L1 adipocytes [J]. Chin J Endocrinol Metab 2007, 4: 351-354.
9. Gu W, Zeng WH, Hu HY, et al. Effects of berberine on adiponectin mRNA expression in 3T3-L1 adipocyte [J]. China J Chin Mater Med, 2005, 4: 286-288.
10. Brusq JM, Ancellin N, Grondin P, et al. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine [J]. J Lipid Res, 2006, 47: 1281-1288.
11. Lee YS, Kim WS, Kim KH, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states [J]. Diabetes, 2006, 55: 2256-2264.
12. Pan GY, Huang ZQ, Wang GJ, et al. The antihyperglycemic activity of berberine arises from a decrease of glucose absorption [J]. Planta Med, 2003, 69: 642-636.
13. Yi P, Lu FE, Xu LJ, et al. Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKbeta [J]. World J Gastroenterol, 2008, 14: 876-883.
14. Kong WJ, Zhang H, Song DQ, et al. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression [J]. Metab Clin Exp, 2009, 58: 109-119.
15. Li SY, Yao YW, Wu R. Effects of berberine hydrochloridum on streptozotocin induced B cells impairment in cultured newborn rat islets [J]. China J Mod Med 2002, 18: 6-10.
16. Liu WJ, Lu FE, Dong H, et al. Effects of berberine on the apoptosis of NIT-1 cells induced by high glucose and saturated fatty acids [J]. Chin J Pathophysiol, 2008, 24: 788-791.
17. Sun H, Lu FE, Wang ZS, et al. Molecular mechanism of berberine's inhibitory effects on the apoptosis of NIT-1 cells induced by high glucose and saturated fatty acids [J]. Chin Pharmacol Bull, 2008, 24: 762-766.
18. Leng SH, Lu FE, Xu LJ. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion [J]. Acta Pharmacol Sin, 2004, 25: 496-502.
19. Wang ZS, Lu FE, Chen G, et al. Effect of berberine on insulin secretion and glucokinase activity of NIT-1 cells [J]. Acta Pharm Sin, 2007, 42: 1045-1049.
20. Wang ZQ, Lu FE, Leng SH, et al. Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity [J]. World J Gastroenterol, 2008, 14: 6004-6011.
21. Ko BS, Choi SB, Park SK, et al. Insulin sensitizing and insulinotropic action of berberine from Coptidis rhizoma [J]. Biol Pharm Bull, 2005, 28: 1431-1437.
22. Kim SH, Shin EJ, Kim ED, et al. Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes [J]. Biol Pharm Bull, 2007, 30: 2120-2125.
23. Zhou L, Wang X, Shao L, et al. Berberine acutely inhibits insulin secretion from beta-cells through 3′, 5′-cyclic adenosine 5′-monophosphate signaling pathway [J]. Endocrinology, 2008, 149: 4510-4518.
24. Chen QM, Xie MZ. Studies on the hypoglycemic effect of Coptis chinensis and berberine [J]. Acta Pharm Sin 1986, 21: 401-406.